ScreenerHero

XLY Auxly Cannabis Group Inc.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · auxly.com
3.460CAD+1.17%Mkt Cap: 257.12M $P/E: 11.03

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap257.12M USD
Enterprise Value268.03M USD
Revenue (TTM)120.58M USD
Gross Profit63.17M USD
Net Income (TTM)30.48M USD
Revenue/Share1.69 CAD
Last Price3.460 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees446
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA05335P1099
Valuation
P/E (Trailing)11.03
P/E (Forward)14.84
PEG—
EV/EBITDA9.27
EV/Revenue2.22
P/S2.13
P/B1.86
EPS (TTM)0.24
EPS (Forward)0.23
52W Range
1.54087% of range3.750
52W High3.750 CAD
52W Low1.540 CAD
Profitability
Gross Margin57.26%
Oper. Margin18.97%
EBITDA Margin23.99%
Profit Margin27.63%
ROE23.57%
ROA15.41%
Growth
Revenue Growth18.00%
Earnings Growth-12.50%
Cash Flow & Leverage
Operating CF19.08M USD
CapEx (TTM)1.83M USD
FCF Margin1.56%
FCF Yield0.73%
Net Debt10.90M USD
Net Debt/EBITDA0.38
Balance Sheet
Debt/Equity0.32
Current Ratio2.35
Quick Ratio1.43
Book Value/Sh1.83 CAD
Cash/Share0.38 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJul 28, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.500 CAD
Upside (mean)+30.1%
Target Range4.000 CAD – 5.000 CAD
4.000+30.1% to mean5.000
# Analysts2
Ownership
Shares Out.103.24M
Float78.60M
Insiders23.08%
Institutions0.63%
Short Interest
Short Ratio5.7d
Short % Out.0.62%
Shares Short643.45K
Short (prev mo.)7.77M
Technical
SMA 503.161 (+9.5%)
SMA 2002.307 (+50.0%)
Beta1.23
S&P 52W Chg14.58%
Avg Vol (30d)132.73K
Avg Vol (10d)149.74K
Technical Indicators
RSI (14)53.7
MACD0.1349
MACD Signal0.1689
MACD Hist.-0.0340
BB Upper3.806 CAD
BB Middle3.418 CAD
BB Lower3.031 CAD
BB Width22.66%
ATR (14)0.1603 CAD
Vol Ratio (20d)1.10x